Leenhardt, F.; Fiteni, F.; Gauthier, L.; Alexandre, M.; Guiu, S.; Firmin, N.; Pouderoux, S.; Viala, M.; Lossaint, G.; Gautier, C.;
et al. Pharmacokinetic Variability Drives Palbociclib-Induced Neutropenia in Metastatic Breast Cancer Patients: Drug–Drug Interactions Are the Usual Suspects. Pharmaceutics 2022, 14, 841.
https://doi.org/10.3390/pharmaceutics14040841
AMA Style
Leenhardt F, Fiteni F, Gauthier L, Alexandre M, Guiu S, Firmin N, Pouderoux S, Viala M, Lossaint G, Gautier C,
et al. Pharmacokinetic Variability Drives Palbociclib-Induced Neutropenia in Metastatic Breast Cancer Patients: Drug–Drug Interactions Are the Usual Suspects. Pharmaceutics. 2022; 14(4):841.
https://doi.org/10.3390/pharmaceutics14040841
Chicago/Turabian Style
Leenhardt, Fanny, Frédéric Fiteni, Ludovic Gauthier, Marie Alexandre, Séverine Guiu, Nelly Firmin, Stéphane Pouderoux, Marie Viala, Gerald Lossaint, Chloé Gautier,
and et al. 2022. "Pharmacokinetic Variability Drives Palbociclib-Induced Neutropenia in Metastatic Breast Cancer Patients: Drug–Drug Interactions Are the Usual Suspects" Pharmaceutics 14, no. 4: 841.
https://doi.org/10.3390/pharmaceutics14040841
APA Style
Leenhardt, F., Fiteni, F., Gauthier, L., Alexandre, M., Guiu, S., Firmin, N., Pouderoux, S., Viala, M., Lossaint, G., Gautier, C., Mollevi, C., Gracia, M., Gongora, C., Mbatchi, L., Evrard, A., & Jacot, W.
(2022). Pharmacokinetic Variability Drives Palbociclib-Induced Neutropenia in Metastatic Breast Cancer Patients: Drug–Drug Interactions Are the Usual Suspects. Pharmaceutics, 14(4), 841.
https://doi.org/10.3390/pharmaceutics14040841